加载中
HKSEHealthcareMedical - Care Facilities
最新数据
HK$17.56
+HK$0.36 · +2.09%
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
最新数据
HK$17.56
+HK$0.36 · +2.09%
盘中时间采用HKT。市场数据可能有所延迟。
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
日内区间
当前HK$17.56
52周区间
当前HK$17.56
盘中时间采用HKT。市场数据可能有所延迟。
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
日内区间
当前HK$17.56
52周区间
当前HK$17.56
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CNY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 30.01亿 CNY | 25.72亿 CNY | 21.45亿 CNY | 16.35亿 CNY | 17.81亿 CNY |
| 销货成本 | 15.29亿 CNY | 13.82亿 CNY | 11.68亿 CNY | 9.18亿 CNY | 9.47亿 CNY |
| 毛利 | 14.72亿 CNY | 11.9亿 CNY | 9.77亿 CNY | 7.18亿 CNY | 8.34亿 CNY |
| 研究与开发 | 4194.2万 CNY | 3603.2万 CNY | 3407.1万 CNY | 3118.7万 CNY | 1802.9万 CNY |
| 销售、一般及管理费用 | 9.93亿 CNY | 8.5亿 CNY | 1.67亿 CNY | 1.71亿 CNY | 1.49亿 CNY |
| 营业费用 | 10.12亿 CNY | 8.68亿 CNY | 6.86亿 CNY | 5.66亿 CNY | 5.56亿 CNY |
| 利息收入 | 2271.4万 CNY | 2361.5万 CNY | 2183.7万 CNY | 309.4万 CNY | 128.3万 CNY |
| 利息支出 | 3216.4万 CNY | 2755.6万 CNY | 2481.1万 CNY | 2471.3万 CNY | 2421.6万 CNY |
| 折旧和摊销 | 4.05亿 CNY | 3.83亿 CNY | 3.32亿 CNY | 2.97亿 CNY | 2.75亿 CNY |
| 营业利润 | 4.6亿 CNY | 3.22亿 CNY | 2.91亿 CNY | 1.52亿 CNY | 2.78亿 CNY |
| 净利润 | 3.18亿 CNY | 2.28亿 CNY | 2.16亿 CNY | 1.03亿 CNY | 1.93亿 CNY |
公司数据更新于 2026年10月14日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P Emerging Markets Small Cap ETFEWX21.84万0.03%6.7亿 USD0.65%US$71.40-0.34%
Dimensional - Emerging Core Equity Market ETFDFAE7.78万0.00%100.47亿 USD0.29%US$38.88-0.46%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM1.86万0.00%96.11亿 USD0.39%US$39.46-0.53%
Avantis Emerging Markets Small Cap Equity ETFAVEE7739.810.01%1.39亿 USD0.42%US$69.23-0.40%State Street SPDR S&P Emerging Markets Small Cap ETFEWXDimensional - Emerging Core Equity Market ETFDFAEDimensional - Emerging Markets Core Equity 2 ETFDFEMAvantis Emerging Markets Small Cap Equity ETFAVEEAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。